-
-
TAZVERIK
- QTY 240
- 200 MG
- Tablet
- Near 77381
TAZEMETOSTAT (TAZ e MET oh stat) treats lymphoma. It may also be used to treat sarcoma, a cancer that occurs in bone and soft tissues, such as fat, muscle, and blood vessels. It works by slowing down the growth of cancer cells. This medication is no longer FDA-approved. Contact your care team about stopping this medication. They can help you find other treatment options.
Change Location
Set Price Drop Alert for:
TAZVERIK
- QTY 240
- 200 MG
- Tablet
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
TAZVERIK
- QTY 240
- 200 MG
- Tablet
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
TAZVERIK Lifestyle Interactions
-
Tazemetostat 200mg, Oral tablet
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during tazemetostat treatment due to the risk for increased tazemetostat exposure and adverse reactions. Tazemetostat is a CYP3A substrate and grapefruit juice is a CYP3A inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
